Treatment Considerations in KRAS NSCLC

 

Treatment Considerations in KRAS NSCLC
04:42

GRACE

NSCLC Panel Discussion: Should a Patient With High PD-L1 Wait for Genetic Testing Results Before Starting Treatment? What Can Patients Do to Close the Biomarker Testing Gap?

FEATURING Kristin Higgins, Aakash Desai, Jessica Lin, Joshua Reuss, Puneeth Iyengar
  • 276 views
  • September 11, 2023
06:29

Insights from 2023 WCLC

WCLC 2023 Insights: "KRYSTAL-1 - Two-Year Follow-Up of Adagrasib Monotherapy in Patients With Advanced/Metastatic KRASG12Cm NSCLC"

FEATURING Shirish Gadgeel
  • 167 views
  • October 9, 2023
  • 2
21:16

GRACE

Targeted Therapies in Lung Cancer 2023: Translating Cancer Discovery - Targeting KRAS G12C in NSCLC

FEATURING Joshua Sabari
  • 138 views
  • August 25, 2023
  • 1
14:45

Yale Cancer Center

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity, Patient Selection, and How to Choose Between Available Agents

FEATURING Amin Nassar
  • 208 views
  • August 22, 2023
  • 1
07:34

Marcelo Negrao

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12Cm NSCLC Who Have Untreated CNS Metastases

  • 461 views
  • July 21, 2023
  • 1
17:07

Nebraska Oncology Society

NOS ASCO® 2023 Review: Targeting Advanced KRAS and EGFR Mutations in NSCLC

FEATURING Vincent Lam
  • 86 views
  • July 3, 2023
  • 4
18:14

Janakiraman Subramanian

Understanding KRAS G12C Positive Lung Cancer

  • 645 views
  • January 6, 2023
  • 7
09:17

Shirish Gadgeel

The Data on Novel KRAS G12C Inhibitors: Focus on Adagrasib

  • 332 views
  • March 13, 2023
  • 3
33:14

Benjamin Herzberg

Direct KRAS Inhibition in NSCLC: Past, Present, and Future

  • 241 views
  • May 12, 2023